HIGHLIGHTS
- who: Zhigan Lv from the Jiangsu University, China have published the research: Molecular Mechanism of Xingnao Kaiqiao Pill for Perioperative Neurocognitive Disorder and Its Correlation With Immune and Inflammatory Signaling Pathways Based on Network Pharmacology and Molecular Docking, in the Journal: (JOURNAL)
- what: This study investigated the mechanism of Xingnao Kaiqiao Pill in the treatment of PND, explained the scientificity and feasibility of traditional Chinese medicine empirical medication from the perspective of molecular biology, and provided a reference for the development of targeted medicines using the TCMSP and the latest technology of Chinese medicine compound . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.